The Swiss International Prostate Center is introducing two cutting-edge tests for the diagnosis of prostate cancer. The first one, Stockholm3, is a blood test used to detect – or to rule out – early stage prostate cancer. It is of particular relevance for men with elevated PSA levels or abnormal MRI findings in whom a…

Read More

Dr. Martins and her team (formed by 4 radiologists), read an average of 35 prostate MRIs a week, which brings the total average to about 1500 exams a year. A number that is rapidly increasing due to the change in guidelines for PCa diagnosis published by the EAU (European Association of Urology) and the ACR…

Read More

First day of the “fistula mission” in Benin and first capsule of Dr. Rochat. This first step is marked by the visit of the Fistula Group team to the urology department of Prof. Josue Avakoudjo, and the meeting with Mathieu Ogoudjobi, fistula focal point at the national level, as well as an exchange with the…

Read More

This year, Clinique Générale-Beaulieu celebrates 20 years of robotic surgery. Back on this success story with the story of a robot, the da Vinci in the field of urology. In March 1999, two urological surgeons, Drs Richard Gaston from Bordeaux and Charles-Henry Rochat from Geneva, collaborated to carry out at the Clinique Générale-Beaulieu the first…

Read More

One in eight men will develop prostate cancer in their lifetime. It is the most common cancer in men, with more than 5,000 new cases being detected in Switzerland each year. Although relatively common, prostate cancer is not inevitable. It is even the cancer that is best cured, in particular thanks to diagnostic methods and…

Read More